Handok to introduce transdermal continuous glucose monitoring system

Handok Pharm announced on June 15 that it has signed a license agreement with the US based Echo Therapeutics, Inc., under which Echo granted Handok to market, sell and distribute Echo's Symphony™ tCGM (transdermal Continuous Glucose Monitoring) system in Korea.

Echo's Symphony™ tCGM System is a next-generation, non-invasive (needle-free), wireless, transdermal continuous glucose monitoring (...